期刊
CELLULAR AND MOLECULAR LIFE SCIENCES
卷 68, 期 2, 页码 289-301出版社
SPRINGER BASEL AG
DOI: 10.1007/s00018-010-0452-1
关键词
Mitogen-activated protein kinase-activated protein kinase MK5; Kinase activity; Diterpenoid alkaloid; Noroxoaconitine; MK5; MK3; ATP binding site; Molecular docking
资金
- Norwegian Cancer Society [A01037]
- Mohn Foundation
The mitogen-activated protein kinase-activated protein kinase MK5 is ubiquitously expressed in vertebrates and is implicated in cell proliferation, cytoskeletal remodeling, and anxiety behavior. This makes MK5 an attractive drug target. We tested several diterpenoid alkaloids for their ability to suppress MK5 kinase activity. We identified noroxoaconitine as an ATP competitor that inhibited the catalytic activity of MK5 in vitro (IC50 = 37.5 mu M; K (i) = 0.675 mu M) and prevented PKA-induced nuclear export of MK5, a process that depends on kinase active MK5. MK5 is closely related to MK2 and MK3, and noroxoaconitine inhibited MK3- and MK5- but not MK2-mediated phosphorylation of the common substrate Hsp27. Molecular docking of noroxoaconitine into the ATP binding sites indicated that noroxoaconitine binds more strongly to MK5 than to MK3. Noroxoaconitine and derivatives may help in elucidating the precise biological functions of MK5 and may prove to have therapeutic values.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据